Cubist Systematic Strategies
TAK icon

Cubist Systematic Strategies’s Takeda Pharmaceutical TAK Stock Holding History

Cubist Systematic Strategies’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-446,764
Closed -$5.92M – 3508
2024
Q4 		$5.92M Buy
+446,764
New +$6.14M 0.04% 733
2024
Q2 		– Sell
-68
Closed -$945 – 3977
2024
Q1 		$945 Buy
+68
New +$989 ﹤0.01% 3600
2023
Q3 		– Sell
-58
Closed -$911 – 3890
2023
Q2 		$911 Sell
58
-89,642
-100% -$1.47M ﹤0.01% 3369
2023
Q1 		$1.48M Buy
89,700
+27,511
+44% +$438K 0.01% 1883
2022
Q4 		$970K Buy
62,189
+32,757
+111% +$458K 0.01% 2477
2022
Q3 		$382K Sell
29,432
-83,010
-74% -$1.15M ﹤0.01% 3361
2022
Q2 		$1.58M Buy
112,442
+50,701
+82% +$724K 0.01% 2072
2022
Q1 		$884K Sell
61,741
-98,995
-62% -$1.45M 0.01% 2131
2021
Q4 		$2.19M Buy
160,736
+122,032
+315% +$1.71M 0.02% 1284
2021
Q3 		$634K Sell
38,704
-23,886
-38% -$401K 0.01% 1862
2021
Q2 		$1.05M Sell
62,590
-80,657
-56% -$1.37M 0.01% 1539
2021
Q1 		$2.62M Buy
143,247
+96,771
+208% +$1.74M 0.03% 856
2020
Q4 		$846K Sell
46,476
-13,902
-23% -$244K 0.01% 1483
2020
Q3 		$1.08M Sell
60,378
-26,176
-30% -$477K 0.02% 1292
2020
Q2 		$1.55M Buy
86,554
+53,695
+163% +$964K 0.03% 940
2020
Q1 		$499K Sell
32,859
-8,148
-20% -$148K 0.01% 1262
2019
Q4 		$809K Buy
41,007
+34,220
+504% +$655K 0.01% 1293
2019
Q3 		$117K Sell
6,787
-40,274
-86% -$697K ﹤0.01% 1904
2019
Q2 		$833K Sell
47,061
-5,423
-10% -$98.7K 0.02% 1145
2019
Q1 		$1.07M Buy
+52,484
New +$1.06M 0.03% 729

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Cubist Systematic Strategies's TAK Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Takeda Pharmaceutical (TAK) in Q1 2025, closing a stake of 446,764 shares — an estimated $5.92M sold.

Cubist Systematic Strategies first reported a position in TAK in Q1 2019 and held it in 20 quarters. The position peaked at $5.92M in Q4 2024. 310 funds tracked by Wall St. Rank hold TAK as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Takeda Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 446,764 Takeda Pharmaceutical shares in Q1 2025, an estimated $5.92M.
  • Cubist Systematic Strategies first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 20 quarters.
  • Cubist Systematic Strategies's Takeda Pharmaceutical position peaked at $5.92M in Q4 2024.
  • 310 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.